Severe anemia associated with increased risk of serious intestinal disorder among very low-birth-weight (VLBW) infants
3/01/2016

Ravi M. Patel, M.D., M.Sc., of the Emory University School of Medicine & Children's Healthcare of Atlanta, and colleagues examined whether red blood cell transfusion and severe anemia were...

Type 1 diabetes raises risk for certain cancers, study finds
3/01/2016

In a new study, type 1 diabetes has been linked to increased risk for certain cancers, including stomach, pancreatic and liver cancers, as well as a lower risk for other cancers.

Severe anemia associated with increased risk of serious intestinal disorder among very low-birth-weight (VLBW) infants
3/01/2016

Ravi M. Patel, M.D., M.Sc., of the Emory University School of Medicine & Children's Healthcare of Atlanta, and colleagues examined whether red blood cell transfusion and severe anemia were...

Gene study uncovers 'spectrum of mutations' in mesothelioma
3/01/2016

A genomic analysis of over 200 mesothelioma tumors uncovers previously unknown mutations - some of which arise in other cancers and may be treatable with existing drugs.

Blood vessels sprout under pressure
3/01/2016

It is blood pressure that drives the opening of small capillaries during angiogenesis. A team of researchers led by Prof.

Study links normal stem cells to aggressive prostate cancer
3/01/2016

A study that revealed new findings about prostate cells may point to future strategies for treating aggressive and therapy-resistant forms of prostate cancer.

Study links normal stem cells to aggressive prostate cancer
3/01/2016

A study that revealed new findings about prostate cells may point to future strategies for treating aggressive and therapy-resistant forms of prostate cancer.

Precision oncology could be tailor-made for metastatic prostate cancer
3/01/2016

Tissue from a single metastasis could provide all the information needed to custom-design therapy for patients with advanced prostate cancer.

Illuminating the broad spectrum of disease
3/01/2016

PRISM efficiently tests drug compounds in multiple cell lines simultaneously, accelerating discovery of targeted therapies in the service of precision medicine.

Breast cancer genetic variants found to alter how cells respond to oestrogen
3/01/2016

An international study of almost 120,000 women has newly identified five genetic variants affecting risk of breast cancer, all of which are believed to influence how breast cells respond to the...